Research


Innovation, R&D, and Pharmaceutical Markets

Working Papers

Abstract: Acquiring a patent can speed an idea’s diffusion or strategically contain it. We study incumbent acquisitions of patented technologies and ask when deals are “acquired to build” versus “acquired to bury.” We develop and estimate a structural model in which firms bid for control and then choose whether to support integration and development or to shelve the technology to avoid cannibalization. The model separates implementation advantages from suppressive incentives and predicts post-acquisition diffusion trajectories and whether acquired knowledge spreads to outside innovators. Counterfactual policy experiments highlight a central trade-off: screening out the most suppressive acquisitions raises diffusion on average, but can also weaken acquisition-based returns and thereby reduce ex ante innovation incentives, potentially discouraging the highest-value breakthroughs.


Work in progress